Home
Department of Clinical Medicine

News archive for Department of Clinical Medicine

Mitochondrial failure contributes to Creutzfeldt-Jacob disease, study suggests.
A new study at the Department of Clinical Medicine and Haukeland University Hospital unfolds important new knowledge about altered gene regulation in Parkinson’s disease.
The CCBIO International Faculty was established to support the Centre through active collaborations and strategic advice. In addition to the 13 already affiliated members, we have now recruited a new member, Marta Bertolaso from Rome, Italy, and have the pleasure of presenting her and her unique contribution to CCBIO.
CCBIO applied for and recently received continued support from the Research Council of Norway (RCN) and the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (DIKU) for phase 2 of the INTPART project: “Bergen-Harvard Cancer Studies phase 2: Continued Partnership for Responsible Education, Research and Innovation Excellence.”
CCBIO operates within the health services in addition to the Faculty of Medicine at the UiB and is subject to the guidelines issued by both institutions (see below links). As a consequence, we are reducing our activities accordingly. Please check the calendar for details. Notably, the CCBIO Annual Symposium and the Satellite Symposium have been cancelled.
February 13-14, the second Mohn Nutrition Research Lab seminar was held.
The coronavirus outbreak (COVID-19) is confirmed as pandemic by WHO, 11. march. To what extent should we fear the coronavirus? We have asked virus expert Professor Rebecca Cox.
CCBIO recently completed its CCBIO903 course Cancer Research: Ethical, Economic and Social Aspects, including a CCBIO Special Seminar, titled “Cancer in the news”. The course is quite unique on a global basis, and recruited participants with a great variety of backgrounds and of geographical locations, such as Bergen (CCBIO), Oslo (Oslo University Hospital, Institute for Cancer Research), London... Read more
The project "Digital technology for personalised management and therapy of hypertensive nephropathy" received 20 million NOK funding from Helse-vest
Kristin Marie Knudsen-Baas presented this poster at the 8th Eilat international course: Pharmacological treatment of epilepsy
Reflections on value and the brain in the context of aging and neurological dysfunction. A presentation by Professor Bernt Engelsen.
Professor Hani Gabra was recently appointed Chief Medical Officer at BerGenBio, based in Oxford UK. Professor Gabra has been part of CCBIO's network of international affiliated researchers since 2016, and considers his affiliation to CCBIO both an advantage and a prerequisite for his role as CMO for BerGenBio. He also finds there are clear opportunities for increased interaction between... Read more
Since CCBIO was established five years ago, 17 students in the Medical Student Research Program have been affiliated to the center's research groups, and several have proceeded to a PhD degree. The students in the program are genuinely interested and dedicated, but also lacking research experience and in need of close follow-up and mentoring. Nevertheless, CCBIO has very good experiences in... Read more
In 2016 CCBIO’s Associate Investigator Professor Daniela Elena Costea received 3 million NOK in funding from the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (https://diku.no/en) for a 3 year collaboration project for education and research in oral pathology and oral cancer between Norway, Moldova, Belarus and Armenia. Due to its achievements, the... Read more
CCBIO hosted the 4th Annual Scandinavian Seminar on Translational Pathology at Solstrand Hotel, Os (Bergen), with 78 dedicated participants from Norway, Sweden and Finland.
Meet a cancer cell in person in five short films.
PhD-candidates and researchers from the Centre for Nutrition participated at the 13th edition of the European Nutrition Conference in Dublin from 15-18th October 2019.
The project Learn About Cancer Through Art is a small scale project financed by the University of Bergen. The project aims at using art as a tool to disseminate knowledge about cancer biology. We collaborate with artists, involve them into active discussions about selected aspects of cancer biology, and challenge them to transform that into art.

Pages